
Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their…

Helical is focused on providing open-source bio foundation models, particularly in the realm of single-cell analysis, enabling scientists to leverage advanced AI tools for their research. Their…
What they do: Build a virtual AI laboratory and application layer for bio foundation models to accelerate drug discovery and therapeutic design
Headquarters: Luxembourg
Stage & team: Seed-stage; team reported ~11–50 employees
Founders: Mathieu Klop, Maxime Allard, Rick Schneider
Notable funding: Seed round (reported $10M); investors include BoxGroup, Frst, Aidan Gomez, Clément Delangue
Accelerating early discovery in pharmaceutical research using AI-driven modeling and in-silico experimentation.
2024
Biotechnology Research
10000000
Dealroom reports a $10M seed led by redalpine with participation from Gradient, BoxGroup, Frst and angels including Aidan Gomez and Clément Delangue
“Includes participation from institutional investors (redalpine, BoxGroup, Frst, Gradient) and notable angel investors (Aidan Gomez, Clément Delangue)”
| Company |
|---|
Helical is building the in-silico labs for biology
Drug discovery still relies on wet labs: slow, expensive, and constrained by physical trial-and-error. Helical is changing that.
We build the application layer that makes Bio Foundation Models usable in real-world drug discovery, enabling pharma and biotech teams to run millions of virtual experiments in days, not years. Today, leading global pharma companies already use Helical, and we’re at the start of a highly ambitious growth journey.
We’re a founder-led, talent-dense team building a category-defining company from Europe. We care deeply about the quality of our work, move fast, and expect ownership. If you’re excited by complexity, real responsibility, and shaping how a company actually operates as it scales, you’ll feel at home here.
At Helical, we’re focused on leveraging research to transform the future of drug discovery. We are seeking an Applied Research Engineer - Post-Training to join our team, focusing on maximizing the performance of cutting-edge foundation models in real-world applications.
Your Role
You will own the full post-training lifecycle for biological foundation models—from alignment strategy to production deployment. This means designing and running pipelines that transform general-purpose models into therapeutic-specific tools for our pharma clients. You'll work directly with real drug discovery problems: adapting models to disease areas, cell types, and perturbation contexts that matter for target identification, hit discovery, and beyond.
This isn't a support role. You'll make core technical decisions about how we extract value from foundation models—what to fine-tune, how to validate it biologically, and how to ship it to customers who are running experiments that inform real clinical programs. You'll collaborate closely with our ML infrastructure and biology teams, but you'll be the person responsible for whether our post-training actually works.
What You'll Do
Requirements
Essentials
Bonus Points
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week